Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Agenda Co-chairs Dr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMA Moderator Dr Gaya Manori Gamhewage, Director, Department of Communication, WHO Welcoming Dr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMA Presentation: WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults Dr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr
C.PenshornM.BeilF
*Correspondence: Yuki Shiimura, [email protected]
Shimobayashi and Kapfhammer, 2021), but less drastic and more common yet to be uncovered gain-of-function mutations may be relevant to psychiatric conditions including anxiety disorders, OCD and manic-depressive illness among others
US$ 24.72
US$ 22.00
US$ 20.74
US$ 23.20
US$ 27.08
